Technology

CCL Industries Announces Q2 Results

By CCL Healthcare

CCL's Q2 highlights include:

Adjusted basic earnings per Class B share of $0.68, up 21.4% earnings per Class B share of $0.63 up 50.0%; currency translation impact nominal
Sales increased 30.5% supported by 5.7% organic sales growth at CCL and strong first full quarter for CCL Secure
Checkpoint continued to deliver solid operating results, 11.4% operating margin
Completed five for one stock split on 5 June, 2017

CCL's six-month highlights include:

Year-to-date adjusted basic earnings per Class B share of £1.25, up 14.7%; basic earnings per Class B share of $1.13, up 21.5%
Sales increased 26.7% supported by 6.2% CCL organic sales growth
Operating income increased 18.5% driven by strong performance at the CCL Segment augmented by acquisitions

For more information, please download this free white paper.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.